Reimagining Neurodegeneration Treatments: Unraveling Proteinopathy and Neuroimmune Signaling

Alzheimer's disease, Parkinson's disease and ALS remain areas of profound unmet need with few treatments and a shortage of mechanism-linked biomarkers. Misfolded proteins drive neuronal dysfunction and degeneration, affecting lysosomal function, lipid metabolism, immune pathways and RNA metabolism; the symposium examines these overlapping pathways to find new targets, biomarkers and mechanisms addressing the downstream effects of protein aggregation, and offers a translational roadmap from molecular mechanism to measurable outcomes and early clinical decisions. The event runs in person and virtually, and abstracts for short talks and posters are invited.